FDA recalls thyroid tablets

News
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

The FDA is recalling thyroid tablets because of potential problems with an ingredient.

The medication is Levothyroxine and Liothyronine in doses of 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg.

The FDA says the Chinese maker of one of the ingredients in the drugs was found to have deficient manufacturing practices in a 2017 inspection.

Patients taking the recalled medicines should continue taking their medicine until they have a replacement product, the FDA said.

Popular

Latest News

More News